A citation-based method for searching scientific literature

Akihiro Yasoda, Yasato Komatsu, Hideki Chusho, Takashi Miyazawa, Ami Ozasa, Masako Miura, Tatsuya Kurihara, Tomohiro Rogi, Shoji Tanaka, Michio Suda, Naohisa Tamura, Yoshihiro Ogawa, Kazuwa Nakao. Nat Med 2004
Times Cited: 258







List of co-cited articles
1190 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dwarfism and early death in mice lacking C-type natriuretic peptide.
H Chusho, N Tamura, Y Ogawa, A Yasoda, M Suda, T Miyazawa, K Nakamura, K Nakao, T Kurihara, Y Komatsu,[...]. Proc Natl Acad Sci U S A 2001
324
61

Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux.
Cynthia F Bartels, Hulya Bükülmez, Pius Padayatti, David K Rhee, Conny van Ravenswaaij-Arts, Richard M Pauli, Stefan Mundlos, David Chitayat, Ling-Yu Shih, Lihadh I Al-Gazali,[...]. Am J Hum Genet 2004
225
45

Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia.
Florence Lorget, Nabil Kaci, Jeff Peng, Catherine Benoist-Lasselin, Emilie Mugniery, Todd Oppeneer, Dan J Wendt, Sean M Bell, Sherry Bullens, Stuart Bunting,[...]. Am J Hum Genet 2012
98
39

Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs.
Naohisa Tamura, Lynda K Doolittle, Robert E Hammer, John M Shelton, James A Richardson, David L Garbers. Proc Natl Acad Sci U S A 2004
197
38

Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias.
Akihiro Yasoda, Hidetomo Kitamura, Toshihito Fujii, Eri Kondo, Naoaki Murao, Masako Miura, Naotetsu Kanamoto, Yasato Komatsu, Hiroshi Arai, Kazuwa Nakao. Endocrinology 2009
77
45

Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation.
Renata Bocciardi, Roberto Giorda, Jens Buttgereit, Stefania Gimelli, Maria Teresa Divizia, Silvana Beri, Silvio Garofalo, Sara Tavella, Margherita Lerone, Orsetta Zuffardi,[...]. Hum Mutat 2007
89
30

Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.
R Shiang, L M Thompson, Y Z Zhu, D M Church, T J Fielder, M Bocian, S T Winokur, J J Wasmuth. Cell 1994
909
27

Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.
Daniel J Wendt, Melita Dvorak-Ewell, Sherry Bullens, Florence Lorget, Sean M Bell, Jeff Peng, Sianna Castillo, Mika Aoyagi-Scharber, Charles A O'Neill, Pavel Krejci,[...]. J Pharmacol Exp Ther 2015
53
49

Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype.
Shunichi Murakami, Gener Balmes, Sandra McKinney, Zhaoping Zhang, David Givol, Benoit de Crombrugghe. Genes Dev 2004
198
24

Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature.
Robert C Olney, Hülya Bükülmez, Cynthia F Bartels, Timothy C R Prickett, Eric A Espiner, Lincoln R Potter, Matthew L Warman. J Clin Endocrinol Metab 2006
113
24

Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice.
Takei Kake, Hidetomo Kitamura, Yuichiro Adachi, Tetsuro Yoshioka, Tomoyuki Watanabe, Hiroaki Matsushita, Toshihito Fujii, Eri Kondo, Takanori Tachibe, Yosuke Kawase,[...]. Am J Physiol Endocrinol Metab 2009
58
41

Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis.
Pavel Krejci, Bernard Masri, Vincent Fontaine, Pertchoui B Mekikian, Maryann Weis, Herve Prats, William R Wilcox. J Cell Sci 2005
103
23

Achondroplasia.
William A Horton, Judith G Hall, Jacqueline T Hecht. Lancet 2007
258
22

An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene.
Kohji Miura, Noriyuki Namba, Makoto Fujiwara, Yasuhisa Ohata, Hidekazu Ishida, Taichi Kitaoka, Takuo Kubota, Haruhiko Hirai, Chikahisa Higuchi, Noriyuki Tsumaki,[...]. PLoS One 2012
70
31

Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.
F Rousseau, J Bonaventure, L Legeai-Mallet, A Pelet, J M Rozet, P Maroteaux, M Le Merrer, A Munnich. Nature 1994
647
22

Statin treatment rescues FGFR3 skeletal dysplasia phenotypes.
Akihiro Yamashita, Miho Morioka, Hiromi Kishi, Takeshi Kimura, Yasuhito Yahara, Minoru Okada, Kaori Fujita, Hideaki Sawai, Shiro Ikegawa, Noriyuki Tsumaki. Nature 2014
120
21


Overgrowth syndrome associated with a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene.
Kohji Miura, Ok-Hwa Kim, Hey Ran Lee, Noriyuki Namba, Toshimi Michigami, Won Joon Yoo, In Ho Choi, Keiichi Ozono, Tae-Joon Cho. Am J Med Genet A 2014
46
45

Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice.
Stéphanie Garcia, Béatrice Dirat, Thomas Tognacci, Nathalie Rochet, Xavier Mouska, Stéphanie Bonnafous, Stéphanie Patouraux, Albert Tran, Philippe Gual, Yannick Le Marchand-Brustel,[...]. Sci Transl Med 2013
54
37

Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature.
Gabriela A Vasques, Naoko Amano, Ana J Docko, Mariana F A Funari, Elisangela P S Quedas, Mirian Y Nishi, Ivo J P Arnhold, Tomonobu Hasegawa, Alexander A L Jorge. J Clin Endocrinol Metab 2013
68
29

An activating mutation in the kinase homology domain of the natriuretic peptide receptor-2 causes extremely tall stature without skeletal deformities.
Sabine E Hannema, Hermine A van Duyvenvoorde, Thomas Premsler, Ruey-Bing Yang, Thomas D Mueller, Birgit Gassner, Heike Oberwinkler, Ferdinand Roelfsema, Gijs W E Santen, Timothy Prickett,[...]. J Clin Endocrinol Metab 2013
50
38

Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway.
A Yasoda, Y Ogawa, M Suda, N Tamura, K Mori, Y Sakuma, H Chusho, K Shiota, K Tanaka, K Nakao. J Biol Chem 1998
154
19

The Local CNP/GC-B system in growth plate is responsible for physiological endochondral bone growth.
Kazumasa Nakao, Kenji Osawa, Akihiro Yasoda, Shigeki Yamanaka, Toshihito Fujii, Eri Kondo, Noriaki Koyama, Naotetsu Kanamoto, Masako Miura, Koichiro Kuwahara,[...]. Sci Rep 2015
41
46

Fibroblast growth factor receptor 3 is a negative regulator of bone growth.
C Deng, A Wynshaw-Boris, F Zhou, A Kuo, P Leder. Cell 1996
832
18

A cluster of translocation breakpoints in 2q37 is associated with overexpression of NPPC in patients with a similar overgrowth phenotype.
Anne Moncla, Chantal Missirian, Pierre Cacciagli, Eve Balzamo, Laurence Legeai-Mallet, Jean-Luc Jouve, Brigitte Chabrol, Martine Le Merrer, Ghislaine Plessis, Laurent Villard,[...]. Hum Mutat 2007
60
28

Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature.
Sophie R Wang, Christina M Jacobsen, Heather Carmichael, Aaron B Edmund, Jerid W Robinson, Robert C Olney, Timothy C Miller, Jennifer E Moon, Veronica Mericq, Lincoln R Potter,[...]. Hum Mutat 2015
54
31

FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway.
Takehiko Matsushita, William R Wilcox, Yuk Yu Chan, Aya Kawanami, Hülya Bükülmez, Gener Balmes, Pavel Krejci, Pertchoui B Mekikian, Kazuyuki Otani, Isakichi Yamaura,[...]. Hum Mol Genet 2009
72
22

Identification and functional characterization of two novel NPR2 mutations in Japanese patients with short stature.
Naoko Amano, Tokuo Mukai, Yoshiya Ito, Satoshi Narumi, Toshiaki Tanaka, Susumu Yokoya, Tsutomu Ogata, Tomonobu Hasegawa. J Clin Endocrinol Metab 2014
46
34

Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.
J S Colvin, B A Bohne, G W Harding, D G McEwen, D M Ornitz. Nat Genet 1996
686
16


C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and -independent pathways.
Hanga Agoston, Sameena Khan, Claudine G James, J Ryan Gillespie, Rosa Serra, Lee-Anne Stanton, Frank Beier. BMC Dev Biol 2007
66
22


Intact kinase homology domain of natriuretic peptide receptor-B is essential for skeletal development.
Rumi Hachiya, Yuko Ohashi, Yasutomi Kamei, Takayoshi Suganami, Hiroshi Mochizuki, Norimasa Mitsui, Masaaki Saitoh, Masako Sakuragi, Gen Nishimura, Hirofumi Ohashi,[...]. J Clin Endocrinol Metab 2007
47
31


Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis.
L Chen, R Adar, X Yang, E O Monsonego, C Li, P V Hauschka, A Yayon, C X Deng. J Clin Invest 1999
186
14


Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormally activated FGFR3 signaling in achondroplasia.
Masaki Matsushita, Hiroshi Kitoh, Bisei Ohkawara, Kenichi Mishima, Hiroshi Kaneko, Mikako Ito, Akio Masuda, Naoki Ishiguro, Kinji Ohno. PLoS One 2013
28
50

Meclozine promotes longitudinal skeletal growth in transgenic mice with achondroplasia carrying a gain-of-function mutation in the FGFR3 gene.
Masaki Matsushita, Satoru Hasegawa, Hiroshi Kitoh, Kensaku Mori, Bisei Ohkawara, Akihiro Yasoda, Akio Masuda, Naoki Ishiguro, Kinji Ohno. Endocrinology 2015
28
50

Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature.
Alfonso Hisado-Oliva, Alba Ruzafa-Martin, Lucia Sentchordi, Mariana F A Funari, Carolina Bezanilla-López, Marta Alonso-Bernáldez, Jimena Barraza-García, Maria Rodriguez-Zabala, Antonio M Lerario, Sara Benito-Sanz,[...]. Genet Med 2018
30
46

C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia.
Ravi Savarirayan, Melita Irving, Carlos A Bacino, Bret Bostwick, Joel Charrow, Valerie Cormier-Daire, Kim-Hanh Le Quan Sang, Patricia Dickson, Paul Harmatz, John Phillips,[...]. N Engl J Med 2019
47
29

Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.
Ami Ozasa, Yasato Komatsu, Akihiro Yasoda, Masako Miura, Yoko Sakuma, Yuko Nakatsuru, Hiroshi Arai, Nobuyuki Itoh, Kazuwa Nakao. Bone 2005
42
30

A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome.
Reha M Toydemir, Anna E Brassington, Pinar Bayrak-Toydemir, Patrycja A Krakowiak, Lynn B Jorde, Frank G Whitby, Nicola Longo, David H Viskochil, John C Carey, Michael J Bamshad. Am J Hum Genet 2006
85
15

A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3.
Y Wang, M K Spatz, K Kannan, H Hayk, A Avivi, M Gorivodsky, M Pines, A Yayon, P Lonai, D Givol. Proc Natl Acad Sci U S A 1999
165
13

Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide.
M Suda, Y Ogawa, K Tanaka, N Tamura, A Yasoda, T Takigawa, M Uehira, H Nishimoto, H Itoh, Y Saito,[...]. Proc Natl Acad Sci U S A 1998
131
13

C-natriuretic peptide: an important regulator of cartilage.
Katerina Pejchalova, Pavel Krejci, William R Wilcox. Mol Genet Metab 2007
45
26


Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification.
Takashi Miyazawa, Yoshihiro Ogawa, Hideki Chusho, Akihiro Yasoda, Naohisa Tamura, Yasato Komatsu, Alexander Pfeifer, Franz Hofmann, Kazuwa Nakao. Endocrinology 2002
84
14

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.
T Sudoh, N Minamino, K Kangawa, H Matsuo. Biochem Biophys Res Commun 1990
928
12

The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.
N Matsukawa, W J Grzesik, N Takahashi, K N Pandey, S Pang, M Yamauchi, O Smithies. Proc Natl Acad Sci U S A 1999
301
12

Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model.
Davide Komla-Ebri, Emilie Dambroise, Ina Kramer, Catherine Benoist-Lasselin, Nabil Kaci, Cindy Le Gall, Ludovic Martin, Patricia Busca, Florent Barbault, Diana Graus-Porta,[...]. J Clin Invest 2016
35
34


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.